REQUEST A DEMO
Total
USD $0.00
Search more companies

Gary Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Gary Pharmaceuticals Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Gary Pharmaceuticals Private Limited is an unlisted company, incorporated on 04/02/2003. It has its registered office in the State of Punjab, India. Company's corporate identification number (CIN) is U24232PB2003PTC025769 and registration number is 025769. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Vpo Heeran, Off-Nh-95, Near Kohara, Chandigarh Road,
Ludhiana; Punjab; Postal Code: 141112

Contact Details: Purchase the Gary Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Gary Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Gary Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Gary Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
February 04, 2003
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Whole Time Director
Company Performance
Financial values in the chart are available after Gary Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
19.78%
Total operating revenue
20.24%
Operating profit (EBIT)
194.21%
EBITDA
79.51%
Net Profit (Loss) for the Period
4616.47%
Total assets
10.14%
Total equity
21.31%
Operating Profit Margin (ROS)
3.22%
Net Profit Margin
7.58%
Return on Equity (ROE)
17.11%
Debt to Equity Ratio
-4.96%
Quick Ratio
0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?